News Content
Core Efficacy 1: Powerful Inhibition of Chronic Lung Inflammation
https://www.fiercerawsource.com/peptides/highgrade-peptide-bronchogen.html
Bronchogen significantly alleviates symptoms such as cough, wheezing, and excessive sputum by downregulating pro-inflammatory factors such as TNF-α and IL-6, blocking the chronic airway inflammatory pathway. Clinical observations show that after use in patients with chronic bronchitis, airway inflammation markers decreased by over 60%, the frequency of cough and wheezing attacks decreased by 73%, and inflammatory cells in sputum were significantly reduced. It can also rapidly reduce oxidative stress and protect the airway mucosal barrier in cases of lung damage induced by smoking, smog, and infection.
Core Efficacy Two: Activating Lung Cell Regeneration and Structural Repair
As a lung tissue repair switch, Bronchogen specifically activates bronchial epithelial stem cells and AT2 alveolar cells, promoting the regeneration of damaged alveolar walls and ciliated epithelium. Animal experiments have confirmed that it can reverse airway remodeling in COPD models, reduce goblet cell proliferation and excessive mucus secretion, and restore the "self-cleaning" function of pulmonary cilia. It also enhances the synthesis of pulmonary surfactant, strengthens alveolar elasticity and gas exchange efficiency, and improves lung diffusion function.
Core Efficacy Three: Delaying Lung Aging and Enhancing Lung Immunity
Its unique DNA stabilizing effect can repair lung cell gene damage and reverse age-related lung function decline. Studies have found that it can enhance respiratory secretory IgA antibody levels, strengthen local lung immunity, and reduce the risk of pneumonia and recurrent infections. Furthermore, it also shows potential for adjuvant repair of difficult lung diseases such as sarcoidosis, interstitial lung disease, and radiation-induced lung injury.
Currently, Bronchogen is mainly used in scientific research and preclinical applications. With its advantages of high targeting, low side effects, and tissue-specific repair, it is moving from the laboratory to the adjunctive treatment of respiratory diseases and lung health management. In the future, it is expected to become an important tool for the intervention of COPD, pulmonary fibrosis, and lung aging.
